Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts

PURPOSE: Metronomic chemotherapy is a minimally toxic and frequently effective new treatment strategy that is beginning to show promising phase II clinical trial results, particularly for metastatic breast cancer when combined with various molecularly targeted antitumor agents. Here, we assessed a t...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Francia, Giulio, Man, Shan, Lee, Chyan-Jang, Lee, Christina R., Xu, Ping, Mossoba, Miriam E., Emmenegger, Urban, Medin, Jeffrey A., Kerbel, Robert S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2788792/
https://ncbi.nlm.nih.gov/pubmed/19825954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0931
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky